EP-1590: Shielding design and fetal dose evaluation of a breast cancer pregnant patient undergoing HDR Ir-192 brachytherapy. (April 2015) - Candela-Juan, C.; Gimeno-Olmos, J.; Pujades, M.C.; Rivard, M.J.; Carmona, V.; Lliso, F.; Celada, F.; Ramírez-Coves, J.L.; Ballester, F.; Tormo, A.; Perez-Calatayud, J.